维普中文期刊产品整合服务
31篇 您的检索式:作者名="Fogar P"
    题名 作者 年代 出处 被引量
1Decreased total lymphocyte counts in pancreatic cancer:an index of adverse outcome显示文摘Fogar P Sperti C Basso D 2006Pancreas2006,32,1:1
2The S100AS/A9 com- plex reduces CTLA4 expression by immature myeloid cells: Implications for pancreatic cancer-driven immuno- suppression显示文摘Basso D Fogar P Plebani M 2013Oncoimmunology2013,2,24:1
3Total PSA, free PSA/total PSA ratio, and molecular PSA detection in prostate cancer: which is clinically effective and when显示文摘Basso D Fogar P Piva M G 2000Urology2000,55,5:1
4Pancreatic cancer-associated diabetes mellitus:an open field for proteomic applications显示文摘Basso D Greco E Fogar P 2005Clin Chim Acta2005,357,2:1
5Portal but not peripheral serum levels of interleukin 6 could interfere with glucose metabolism in patients with pancreatic cancer 显示文摘Fogar P Basso D Pasquali C 1998Clin Chim Acta1998,272,2:1
6Pancreatic cancer-derived S-100A8 N-terminal peptide:a diabetes cause?显示文摘Basso D Greco E Fogar P 2006Clin Chim Acta2006,372,2:1
7Non-invasive diagnosis of Helicobacter pylori infection: simplified 13Curea breath test,stool antigen testing or DNA PCR in human faeces in a clinical laboratory setting显示文摘Zambon CF Basso D Navaglia F Mazza S Razetti M Fogar P 2004Clin Biochem2004,37,4:1
8Decreased tolai lymphocyte counts in pancreatic cancer: an index of adverse outcome 显示文摘Fogar P Sperti C Basso D 2006Pancreas2006,32,:1
9Pancreatic cancer-associated diabetes mellitus: an open field for proteomic applications显示文摘Basso D Grecn E Fogar P 2005Clin Chim Acta2005,375,2:1
10Pancreatic cancer:associated diabetes mellitus:an open field for proteomic applications显示文摘Basso D Greco E Fogar P 2005Clin Chim Acta2005,375,2:1
11Pancreatic cancer-derived S100A8 N-terminal peptide: a diabetes cause? 显示文摘Basso D Greco E Fogar P 2006Clin Chirn Acta2006,372,12:1
12Glucose transporter-1 expression and prognostic significance in pancreatic carcinogenesis显示文摘Pizzi S Porzionato A Pasquali C Guidolin D Sperti C Fogar P 2009Histol Histopathol2009,24,2:1
13Insulin-like growth factor- Ⅰ, interleukin-1 alpha and beta in pancreatic cancer:role in tumor invasiveness and associated diabetes显示文摘 Plebani M Fogar P 1995Int J Clin Lab Res1995,25,1:1
14Diabetes mellitus in pan- creatic cancer followup显示文摘Fogar P Pasquali C Basso D 1994Anticancer Res1994,14,6:1
15Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of- flight mass spectrometry显示文摘Navaglia F Fogar P Basso D 2009Clin Chem Lab Med2009,47,:1
16Killer genes in pancreatic cancer therapy 显示文摘Fogar P Greco E Basso D 2005Cell Mol Biol (Noisy-le-grand)2005,51,1:1
17Suicide gene therapy with HSV-TK in pancreatic cancer has no effect in vivo in a mouse model显示文摘Fogar P Greco E Basso D 2003Eur J Surg Oncol2003,29,9:1
18Suicide gene therapy with the yeast fusion gene cytosine deaminase/uracil phosphoribosyltransferase is not enough for pancreatic cancer显示文摘Fogar P Navaglia F Basso D 2007Pancreas2007,35,3:1
19C - peptide pattern in patients with pancreatic cancer显示文摘Fogar P Basso D Panozzo M P 1993Anticancer Res1993,13,:1
20Pancreatic cancer-derived S-100A8 N-terminal peptide:A diabetes cause?显示文摘Basso D Greco E Fogar P 2006Clin Chim Acta2006,372,2:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费